GlassScriptPhysician profile
Thomas L Wicks
NPI 1265413694
$6,247.31
in general payments reported to CMS, 2019-2025
21 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,709 · 2020: $14.97 · 2021: $86.80 · 2022: $1,449 · 2023: $166 · 2024: $1,464 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,013 · Food and Beverage: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,012.77 |
| Food and Beverage | $974.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,352.56 | 2022-2024 | Trabecular Metal |
| Organogenesis INC. | $1,495.71 | 2019-2025 | Apligraf, Cygnus Matrix, Puraply Am |
| Pylant Medical | $972.00 | 2019 | |
| Smith+Nephew, INC. | $452.79 | 2019-2025 | Collagenase Santyl, Grafix |
| Averitas Pharma INC. | $353.02 | 2024-2025 | Qutenza |
| Stryker Corporation | $166.23 | 2019-2023 | Blueprint Patient Specific Instrumentation |
| Melinta Therapeutics, LLC | $81.03 | 2019 | |
| Paratek Pharmaceuticals, INC. | $73.42 | 2023-2025 | Nuzyra |
| Integra Lifesciences Corporation | $40.55 | 2023-2024 | Tenoglide, Tcc-Ez |
| Kerecis Limited | $40.33 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Solventum Corporation | $35.49 | 2024 | Activ.A.C. |
| Vertex Pharmaceuticals Incorporated | $29.58 | 2025 | |
| P Bar Medical LLC | $22.98 | 2025 | |
| Treace Medical Concepts, INC. | $20.75 | 2024 | |
| Kci USA, INC. | $20.48 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.85 | 2022 | |
| Reapplix INC. | $17.83 | 2021 | |
| Deroyal Industries, INC. | $14.66 | 2024 | Flex Npwt Single Use System |
| Convatec INC. | $14.59 | 2024 | |
| Bioventus LLC | $14.37 | 2025 | Exogen Ultrasound Bone Healing System |
| Medela LLC | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.